Table 2.
For the Indian and multinational trials in Phase 3, the number and percentage of sites in each zone.
Trials in each zone | 163 Indian trials |
28 multinational trials |
||
---|---|---|---|---|
Number of sites | Percentage | Number of sites | Percentage | |
Western | 362 | 34.5 | 110 | 31.5 |
Southern | 254 | 24.2 | 132 | 37.8 |
Northern | 195 | 18.6 | 52 | 14.9 |
Central | 113 | 10.8 | 22 | 6.3 |
Eastern | 107 | 10.2 | 31 | 8.9 |
North-Eastern | 18 | 1.7 | 2 | 0.6 |
Total | 1049 | 100 | 349 | 100 |